armata investors

Investors Overview

Stock Quote: ARMP

NYSE AmericanARMP
Price

$

Change

High

$00.00

View Details

Minimum 15 minutes delayed.

Latest Press Releases
Nov 12, 2019
Armata Pharmaceuticals Announces Third Quarter Results and Provides Corporate and Clinical Update

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for...

Oct 31, 2019
Armata Pharmaceuticals Issues Letter to Shareholders

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections,...

Oct 21, 2019
Armata Pharmaceuticals Announces Receipt of $1.3 million R&D Tax Incentive

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections,...